UK markets open in 5 hours 32 minutes
NIKKEI 225
26,859.18 +643.39 (+2.45%) HANG SENG
17,079.51 -143.32 (-0.83%) CRUDE OIL
83.92 +0.29 (+0.35%) GOLD FUTURES
1,706.30 +4.30 (+0.25%) DOW
29,490.89 +765.38 (+2.66%) BTC-GBP
17,270.16 +232.22 (+1.36%)
Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.5700 |
| Open | 2.5700 |
| Bid | 2.5700 x 900 |
| Ask | 2.6100 x 1100 |
| Day's range | 2.5000 - 2.6650 |
| 52-week range | 1.6000 - 5.4100 |
| Volume | |
| Avg. volume | 371,338 |
| Market cap | 143.74M |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.1780 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | 18.50 |
- Simply Wall St.
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Is Expected To Breakeven In The Near Future
Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) is possibly approaching a major achievement in its business, so we would...
- Motley Fool
Paratek Pharmaceuticals (PRTK) Q2 2022 Earnings Call Transcript
Participants on today's call are Evan Loh, M.D., chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
- Zacks
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
Paratek (PRTK) delivered earnings and revenue surprises of 5.71% and 3.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
